O'Connell, R. J., Excler, J., Polonis, V. R., Ratto-Kim, S., Cox, J., Jagodzinski, L. L., . . . Kim, J. H. (2016). Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene. J Infect Dis.
Chicago Style CitationO'Connell, Robert J., et al. "Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene." J Infect Dis 2016.
Cita MLAO'Connell, Robert J., et al. "Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene." J Infect Dis 2016.